InsiderTrades

Form 4 for BVS Bioventus Inc.

Accepted 2026-06-04 16:46:43 ET · period of report 2026-06-02 · accession 0001760737-26-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-06-04 16:46 2026-06-02 BVS Ladone Mary Kay Dir M - OptEx $0.00 +32.3K 111.3K +41% $0
D 2026-06-04 16:46 2026-06-02 BVS Ladone Mary Kay Dir M - OptEx $0.00 -32.3K 0 -100% $0
D 2026-06-04 16:46 2026-06-03 BVS Ladone Mary Kay Dir A - Grant $0.00 +25.1K 25.1K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2026-06-02 M A 32,282 $0.00 111,263 D — —
2 Derivative Restricted Stock Units 2026-06-02 M D 32,282 $0.00 0 D — · — to — 32,282 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F2) The RSUs vested on June 2, 2026. (F2) The RSUs vested on June 2, 2026.
3 Derivative Restricted Stock Units 2026-06-03 A A 25,146 $0.00 25,146 D — · — to — 25,146 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F3) The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. (F3) The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.